A common variant in the adiponectin gene and polycystic ovary syndrome risk

[1]  M. Zali,et al.  Start codon FokI and intron 8 BsmI variants in the vitamin D receptor gene and susceptibility to colorectal cancer , 2011, Molecular Biology Reports.

[2]  B. Musellim,et al.  The association between BsmI variant of vitamin D receptor gene and susceptibility to tuberculosis , 2011, Molecular Biology Reports.

[3]  M. Zali,et al.  Influence of gene variants related to calcium homeostasis on biochemical parameters of women with polycystic ovary syndrome , 2011, Journal of Assisted Reproduction and Genetics.

[4]  N. Bukan,et al.  Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters , 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[5]  Z. Ezabadi,et al.  Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. , 2010, Fertility and sterility.

[6]  T. Mahmoudi.  Genetic variation in the vitamin D receptor and polycystic ovary syndrome risk. , 2009, Fertility and sterility.

[7]  N. Shah,et al.  Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome. , 2009, European journal of endocrinology.

[8]  Z. Hochberg,et al.  Rickets in the Middle East: role of environment and genetic predisposition. , 2008, The Journal of clinical endocrinology and metabolism.

[9]  H. Ostrer,et al.  Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. , 2008, Cancer research.

[10]  Ning Zhang,et al.  Association of +45G15G(T/G) and +276(G/T) polymorphisms in the ADIPOQ gene with polycystic ovary syndrome among Han Chinese women. , 2008, European journal of endocrinology.

[11]  K. Baek,et al.  Single nucleotide polymorphism in exon 17 of the insulin receptor gene is not associated with polycystic ovary syndrome in a Korean population. , 2006, Fertility and sterility.

[12]  R. Kimmig,et al.  Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[13]  F. Kronenberg,et al.  Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. , 2006, Diabetes.

[14]  E. Carlsson,et al.  A polymorphism in the adiponectin gene influences adiponectin expression levels in visceral fat in obese subjects , 2006, International Journal of Obesity.

[15]  S. Vasdev,et al.  Altered calcium homeostasis is correlated with abnormalities of fasting serum glucose, insulin resistance, and beta-cell function in the Newfoundland population. , 2005, Diabetes.

[16]  E. Diamanti-Kandarakis,et al.  Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. , 2005, Clinical chemistry.

[17]  H. Knobler,et al.  Polycystic ovary syndrome in post-menopausal women--marker of the metabolic syndrome. , 2005, Maturitas.

[18]  J. L. San Millán,et al.  The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. , 2005, Endocrine reviews.

[19]  I. Papassotiriou,et al.  Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. , 2005, Clinical chemistry.

[20]  A. Tsatsoulis,et al.  Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of Delta4-androstenedione. , 2004, Human reproduction.

[21]  J. L. San Millán,et al.  Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. , 2004, The Journal of clinical endocrinology and metabolism.

[22]  E. Grundberg,et al.  Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women. , 2004, European journal of endocrinology.

[23]  M. Hill,et al.  Serum parathyroid hormone levels are associated with FokI polymorphism of the vitamin D receptor gene in untreated postmenopausal women. , 2003, European journal of internal medicine.

[24]  Lee-Ming Chuang,et al.  Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity , 2003, Journal of Molecular Medicine.

[25]  E. Lander,et al.  Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease , 2003, Nature Genetics.

[26]  Y. Tomer,et al.  A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome. , 2002, Fertility and sterility.

[27]  Y. Tomino,et al.  Parathyroid hormone gene polymorphism and secondary hyperparathyroidism in hemodialysis patients. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  E. Barrett-Connor,et al.  Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. , 2002, Metabolism: clinical and experimental.

[29]  J. Ioannidis,et al.  Replication validity of genetic association studies , 2001, Nature Genetics.

[30]  J. Chan,et al.  An insulin receptor gene polymorphism is associated with diastolic blood pressure in Chinese subjects with components of the metabolic syndrome. , 2000, American journal of hypertension.

[31]  K. Chihara,et al.  Parathyroid hormone gene polymorphisms in primary hyperparathyroidism , 1999, Clinical endocrinology.

[32]  D. Waterworth,et al.  Genetics of polycystic ovary syndrome , 1998, Molecular and Cellular Endocrinology.

[33]  A. Dunaif,et al.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. , 1997, Endocrine reviews.

[34]  S. Franks,et al.  Polycystic ovary syndrome. , 1995, Archives of disease in childhood.

[35]  J. Eisman,et al.  Prediction of bone density from vitamin D receptor alleles , 1994, Nature.

[36]  B. K. Saha,et al.  Characterization of two novel polymorphisms at the human parathyroid hormone gene locus , 1992, Human Genetics.

[37]  C. Hanis,et al.  Identification of an insulin receptor exon 8 NsiI polymorphism using the polymerase chain reaction. , 1990, Nucleic acids research.

[38]  O. Gedik,et al.  Effects of Hypocalcemia and Theophylline on Glucose Tolerance and Insulin Release in Human Beings , 1977, Diabetes.

[39]  G. Velho,et al.  Identification of a novel Tru9 I polymorphism in the human vitamin D receptor gene , 2000, Journal of Human Genetics.

[40]  G. Okoev,et al.  [Diagnostic criteria for polycystic ovary syndrome]. , 1989, Akusherstvo i ginekologiia.